Bioter SA (Greece) Performance
| BIOT Stock | EUR 0.29 0.03 9.38% |
On a scale of 0 to 100, Bioter SA holds a performance score of 7. The firm shows a Beta (market volatility) of -0.0892, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bioter SA are expected to decrease at a much lower rate. During the bear market, Bioter SA is likely to outperform the market. Please check Bioter SA's standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Bioter SA's price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bioter SA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Bioter SA unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Price Earnings Ratio | 0.9613 | |
| Total Cashflows From Investing Activities | 1.7 M |
Bioter |
Bioter SA Relative Risk vs. Return Landscape
If you would invest 24.00 in Bioter SA on August 28, 2024 and sell it today you would earn a total of 5.00 from holding Bioter SA or generate 20.83% return on investment over 90 days. Bioter SA is generating 0.3958% of daily returns and assumes 4.3894% volatility on return distribution over the 90 days horizon. Simply put, 39% of stocks are less volatile than Bioter, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bioter SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioter SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bioter SA, and traders can use it to determine the average amount a Bioter SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0902
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BIOT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.39 actual daily | 39 61% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Bioter SA is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioter SA by adding it to a well-diversified portfolio.
Bioter SA Fundamentals Growth
Bioter Stock prices reflect investors' perceptions of the future prospects and financial health of Bioter SA, and Bioter SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioter Stock performance.
| Return On Asset | -0.0136 | |||
| Operating Margin | (7.66) % | |||
| Current Valuation | 166.03 M | |||
| Shares Outstanding | 16.73 M | |||
| Price To Earning | (0.07) X | |||
| Price To Sales | 17.36 X | |||
| Revenue | 241 K | |||
| EBITDA | (1.76 M) | |||
| Cash And Equivalents | 255 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 143.2 M | |||
| Book Value Per Share | (6.07) X | |||
| Cash Flow From Operations | (6.38 M) | |||
| Earnings Per Share | 0.36 X | |||
| Total Asset | 100 M | |||
| Retained Earnings | (109 M) | |||
| Current Asset | 36 M | |||
| Current Liabilities | 133 M | |||
About Bioter SA Performance
Assessing Bioter SA's fundamental ratios provides investors with valuable insights into Bioter SA's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bioter SA is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Bioter S.A. operates as a construction company in Greece and internationally. The company was founded in 1962 and is based in Athens, Greece. BIOTER S is traded on Athens Stock Exchange in Greece.Things to note about Bioter SA performance evaluation
Checking the ongoing alerts about Bioter SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioter SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioter SA has some characteristics of a very speculative penny stock | |
| Bioter SA had very high historical volatility over the last 90 days | |
| Bioter SA has high likelihood to experience some financial distress in the next 2 years | |
| Bioter SA has accumulated 143.2 M in total debt. Bioter SA has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bioter SA until it has trouble settling it off, either with new capital or with free cash flow. So, Bioter SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioter SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioter to invest in growth at high rates of return. When we think about Bioter SA's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 241 K. Net Loss for the year was (8.81 M) with loss before overhead, payroll, taxes, and interest of (935 K). | |
| Bioter SA has accumulated about 255 K in cash with (6.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 42.0% of the company shares are held by company insiders |
- Analyzing Bioter SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioter SA's stock is overvalued or undervalued compared to its peers.
- Examining Bioter SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioter SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioter SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioter SA's stock. These opinions can provide insight into Bioter SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bioter Stock Analysis
When running Bioter SA's price analysis, check to measure Bioter SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioter SA is operating at the current time. Most of Bioter SA's value examination focuses on studying past and present price action to predict the probability of Bioter SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioter SA's price. Additionally, you may evaluate how the addition of Bioter SA to your portfolios can decrease your overall portfolio volatility.